56
Participants
Start Date
August 2, 2022
Primary Completion Date
January 17, 2026
Study Completion Date
December 12, 2026
Vonsetamig
Administered by intravenous (IV) infusion
RECRUITING
New York University Langone Health, New York
RECRUITING
Penn Transplant Institute, Philadelphia
RECRUITING
Medstar Georgetown Transplant Institute - 2-PHC, Washington D.C.
RECRUITING
John Hopkins Hospital, Baltimore
RECRUITING
University of Minnesota, Minneapolis
RECRUITING
Comprehensive Transplant Center, Chicago
RECRUITING
Cedars-Sinai Medical Center, Los Angeles
RECRUITING
University of California Irvine, Orange
RECRUITING
Connie Frank Transplant Center at UCSF, San Francisco
RECRUITING
Yale University of Medicine, New Haven
Regeneron Pharmaceuticals
INDUSTRY